Evidence map›Paper›PMID 40172959›Full record

ArticleeLife2025

Redox regulation and dynamic control of brain-selective kinases BRSK1/2 in the AMPK family through cysteine-based mechanisms.

George N Bendzunas, Dominic P Byrne, Safal Shrestha, Leonard A Daly, Sally O Oswald, Samiksha Katiyar, Aarya Venkat, Wayland Yeung, Claire E Eyers, Patrick A Eyers and 1 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Investigating the Regulation of Ribosomal Protein S6 Kinase 1 by CoAlation.International journal of molecular sciences · 2024
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

George N Bendzunas *Department of Biochemistry and Molecular Biology, University of Georgia, Athens, United States.ORCID https://orcid.org/0000-0001-5986-7862
Dominic P Byrne *Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.ORCID https://orcid.org/0000-0001-5197-345X
Safal ShresthaInstitute of Bioinformatics, University of Georgia, Athens, United States.
Leonard A DalyDepartment of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Sally O OswaldDepartment of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Samiksha KatiyarDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, United States.
Aarya VenkatDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, United States.ORCID https://orcid.org/0000-0002-8793-4097
Wayland YeungDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, United States.
Claire E EyersDepartment of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.ORCID https://orcid.org/0000-0002-3223-5926
Patrick A EyersInstitute of Bioinformatics, University of Georgia, Athens, United States.ORCID https://orcid.org/0000-0002-9220-2966
Natarajan KannanDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, United States.ORCID https://orcid.org/0000-0002-2833-8375

Funding

Unlocking sequence-structure-function-disease relationships in large protein super-familiesR35GM139656 · NIGMS · UNIVERSITY OF GEORGIA · PI KANNAN, NATARAJAN · 2021 to 2025
$2.2M
Biotechnology and Biological Sciences Research Council BB/N021703/1Biotechnology and Biological Sciences Research Council BB/S018514/1Biotechnology and Biological Sciences Research Council BB/X002780/1NIGMS NIH HHS R35 GM139656NIH HHS R35 GM139656North West Cancer Research CR1208University of Liverpool BBSRC MRC/IAA awards
6 · The paper itself

Abstract

In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.

Indexed as

AMP-Activated Protein KinasesBrainCysteineProtein Serine-Threonine KinasesAnimalsHumansMolecular Dynamics SimulationOxidation-ReductionPhosphorylationProtein Processing, Post-TranslationalAMP-Activated Protein KinasesCysteineProtein Serine-Threonine Kinasesallosterycomputational biologyconformationcovalent inhibitorsdrug discoveryE. colihumanprotein evolutionredox regulationsystems biology

Identifiers

PMID40172959
PMCPMC11964447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.